Iron Supplementation Does Not Cause a Rise in Bilirubin
Iron supplementation itself does not directly cause elevated bilirubin levels. In fact, the relationship between iron and bilirubin is more complex and typically inverse in clinical practice.
The Iron-Bilirubin Relationship
Iron supplementation is a standard treatment for iron deficiency anemia, with clear guidelines recommending oral iron (ferrous sulfate 200 mg daily or 50-100 mg elemental iron) as first-line therapy 1, 2. None of the major clinical practice guidelines for iron deficiency anemia, hemochromatosis, or chronic kidney disease mention bilirubin elevation as a side effect or complication of iron supplementation 3, 1, 2, 3, 4, 5.
When Bilirubin and Iron Are Both Elevated
The scenarios where you might see both elevated iron and bilirubin involve hemolysis (red blood cell breakdown), not iron supplementation:
- Hemolytic conditions release both iron and bilirubin simultaneously from destroyed red blood cells 6, 7
- In hemochromatosis with advanced liver disease, hyperbilirubinemia can occur due to hepatic dysfunction, not from the iron itself 8
- Transfusion of stored red blood cells can increase both iron and bilirubin markers due to hemolysis 9
Research Evidence on Iron and Oxidative Stress
One study found that iron supplementation increased oxidative stress markers (TBARS) after muscle injury, while bilirubin actually decreased following eccentric exercise in both supplemented and non-supplemented groups 10. This demonstrates that iron supplementation does not raise bilirubin; if anything, the two move in opposite directions under stress conditions.
Clinical Implications
If a patient on iron supplementation develops elevated bilirubin, look for alternative causes:
- Hemolysis (check hemoglobin, haptoglobin, LDH, reticulocyte count)
- Liver disease (check ALT, AST, alkaline phosphatase)
- Gilbert's syndrome or other inherited hyperbilirubinemias
- Concurrent medications or conditions affecting bilirubin metabolism
The common side effects of oral iron supplementation are gastrointestinal (nausea, constipation, dark stools), not hyperbilirubinemia 1, 2.
Important Caveat
In patients with cyanotic congenital heart disease who develop iron deficiency from overly aggressive phlebotomy, iron supplementation must be monitored carefully as it can cause rapid increases in red cell mass 11, 12. However, this relates to hematocrit changes, not bilirubin elevation.